Department of Pharmacology, Tabula Rasa Healthcare, Precision Pharmacotherapy Research and Development Institute, USA
Case Report
Angiotensin Converting Enzyme (ACE) Inhibitor-Induced Cough Resulting in Prescribing Cascade
Author(s): Stacy-Ann Wright, Chandni Bardolia, David Bankes, Nishita Shah Amin* and Jacques Turgeon
Objective: Prescribing cascade usually results from the misdiagnosis of a drug-related adverse event or condition. Although the prevalence of prescribing cascade remains unknown, it likely increases the risks associated with polypharmacy (e.g., adverse drug events). Furthermore, consequences of prescribing cascade are more likely to be detrimental for the elderly population due to the presence of multiple chronic diseases and the complexity of the derived medication regimen. This case aims to shed light on a particular prescribing cascade due to angiotensinconverting enzyme (ACE) inhibitor-induced cough.
Case: A 101-year-old male with a past medical hypertension, osteoarthritis, gastroesophageal reflux disease, atrial fibrillation, hyperlipidemia, muscle weakness, and mild intermittent asthma was experiencing worsening of cough. To manage hi.. Read More»
DOI:
10.37421/jccr.2020.10.1368
Journal of Clinical Case Reports received 1345 citations as per Google Scholar report